Scarica l'app Stockscreener
0.2999
22.10%
-0.0851
Dopo l'orario di chiusura:
.30
0.000100
+0.03%
Allurion Technologies Inc Borsa (ALUR) Ultime notizie
Why did Allurion stock surge over 50% today? - MSN
Death Cross: How Allurion Technologies Inc. stock valuations compare to rivalsWeekly Trade Review & Target Return Focused Stock Picks - Naître et grandir
Intercontinental Exchange : NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) - marketscreener.com
GN Store Nord (OTCMKTS:GNNDY) and Allurion Technologies (NYSE:ALUR) Financial Survey - Defense World
CPUHCompute Health Acquisition Corp. Warrant Holders Hold Special Meeting - ADVFN Ltd
8 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session - Benzinga
NYSE initiates delisting proceedings against Allurion By Investing.com - Investing.com Canada
Allurion Technologies Appeals NYSE Delisting, Plans Compliance Strategy - The Globe and Mail
RTW funds report 39.4% Allurion (ALUR) ownership in 13D amendment - Stock Titan
NYSE initiates delisting proceedings against Allurion - Investing.com
Allurion intends to appeal NYSE notice of delisting, execute plan to regain compliance, and expects to continue trading on NYSE - marketscreener.com
ALLURION TECHNOLOGIES announced that the company plans to formally appeal the delisting notice issued by the New York Stock Exchange. - Bitget
Allurion Technologies Received Notice of Delisting - TradingView
NYSE moves to delist Allurion (NYSE: ALUR) as company plans appeal - Stock Titan
Nyse to commence delisting proceedings against Allurion Technologies, Inc. - marketscreener.com
Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE - Business Wire
NYSE To Commence Delisting Proceedings Against Allurion Technologies, Inc. - TradingView
NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) - FinancialContent
Allurion Technologies (NYSE:ALUR) & CeriBell (NASDAQ:CBLL) Head-To-Head Survey - Defense World
ALUR Should I Buy - Intellectia AI
Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year? - Yahoo Finance
What's going on with Allurion stock on Wednesday? - MSN
FDA approves Allurion’s gastric balloon system - BioWorld MedTech
Contrasting Allurion Technologies (NYSE:ALUR) and Metastat (OTCMKTS:MTST) - Defense World
What's Going On With Allurion Stock On Wednesday? - Benzinga
Allurion Technologies amends warrant terms and raises $3 million through inducement offer - Investing.com Nigeria
Allurion Technologies Amends Warrants to Bolster Liquidity - TipRanks
Allurion Lowers Warrant Exercise Price to $1.15, Raises ~$3M and Issues 5.32M New Warrants - TradingView
Allurion Technologies (ALUR) secures $3M via warrant repricing and new warrants - Stock Titan
Why Did Allurion Stock Surge Over 50% Today? - Stocktwits
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session - Benzinga
Nasdaq Gains Over 1%; Keurig Dr Pepper Earnings Top Views - Benzinga
Chardan Capital Upgrades Allurion Technologies (ALUR) - Nasdaq
Strategic Acquisition Amplifies Allurion’s Market Presence - StocksToTrade
Dow Gains Over 100 Points; Home Depot Posts Upbeat Earnings - Benzinga
Allurion Technologies upgraded to Buy from Neutral at Chardan - TipRanks
Allurion Technologies stock rating upgraded on FDA approval By Investing.com - Investing.com India
Allurion stock balloons as FDA signs off on weight loss device - Fierce Biotech
ALUR Sees Market Volatility Amidst Strategic Moves and Market Challenges - timothysykes.com
Allurion Technologies stock rating upgraded on FDA approval - Investing.com UK
Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds - Business Wire
Chardan Upgrades Allurion Technologies to Buy From Neutral, $3 Price Target - marketscreener.com
Earnings Recap: Is KOPN in a bullish channelJuly 2025 Market Mood & Accurate Buy Signal Alerts - baoquankhu1.vn
FDA approves Allurion gastric balloon for obesity treatment By Investing.com - Investing.com Australia
FDA Approves Swallowable Balloon for Weight Loss. How Does It Compare to GLP-1 Drugs? - TODAY.com
Dow Tumbles Over 700 Points; Dominion Energy Posts Upbeat Earnings - Benzinga
Allurion Wins FDA Nod for Alternative to GLP-1s - Medical Device and Diagnostic industry
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session - Benzinga
Allurion Technologies Says Gastric Balloon System to Treat Obesity Premarket Approval Application Approved by FDA - marketscreener.com
ALUR | Allurion Technologies, Inc. FinancialsIncome Statement - Quiver Quantitative
Allurion gets FDA nod for weight loss balloon - MassDevice
Allurion Technologies Wins FDA's PMA Approval For Allurion Gastric Balloon System, Stock Soars - Nasdaq
Allurion Gets FDA Approval for Gastric Balloon System with Smart Capsule - Medical Product Outsourcing
Allurion’s Strategic Partnership to Boost Weight Loss Solutions - StocksToTrade
Allurion Wins FDA Approval for Gastric Balloon System - TipRanks
Allurion Technologies Surge: Argentine Partnership Enhances Foreign Market Strategy - timothysykes.com
FDA approves Allurion gastric balloon for obesity treatment - Investing.com
Allurion receives FDA PMA approval for gastric balloon system featuring Smart Capsule - TradingView
Allurion stock surges 40% on U.S. FDA approval By Investing.com - Investing.com South Africa
Allurion stock surges 40% on U.S. FDA approval - Investing.com India
Allurion Receives U.S. FDA Approval - The Joplin Globe
1.69%
1.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):